Questions sent to DM for webinar of 3 DecFollowing are questions sent to DM, in anticipation to tomorrow's webinar. Several will, undoubtedly, be repeats from others, but it's probably not a bad thing that they get these from a breadth of shareholders.
In a nutshell, there are 10 questions (
in bold red)with a bit of context.
Questions: DM webinar 03 December, 2020
Following are 10 questions touching on 1) follow-up to the last AGM 2) AI 3) COVID-19 4) PR Strategy and 5) Other broader general issues.
-
October 2020 AGM follow-up:
Reverse Split. During the AGM there was confusion as to whether the RS was supported, or not, by shareholders. It was initially said that it was not supported but then that TSX indicated 68% of shareholders supported it. AGM attendees were told the final outcome would be announced later but no subsequent feedback was provided.
Q1: Could DM advise on the final outcome of the RS shareholder vote?
-
AI. A number of announcements have been made over the past months regarding AI opportunities. (Nexalogy SMART; South Korea; Pandemic Management System)
Q2: Could we have a broad update on the following?
-
Nexalogy SMART.
-
$40 M IDEaS Milestone 4 co-bid - developing Nexalogy SMART.
-
Nexalogy-driven US-based contracts ( a) Carnegie Mellon University; b) Democracy Labs (#SeeSay2020 campaign), c) US government one-month USD 25,000 contract labelled as a pilot representing “...a major milestone for the Company as it is the natural progression to potentially expand into the US market, specifically the US Government.”
-
NATO presentation, follow up to the October 2019 DM presented Canadian Election Fake News findings to Nato.
-
USAF. In July 2020 second contract with USAF via Wright State Applied Research Corp. ("WSARC"), the University and the state of Ohio, and head the U.S. Air Force Academic Partnership and Engagement Experiment (APEX) program announcement
-
South Korea: (Lotte, Sees/Samsung, RPA; Lotte-DM Korean Ministry of Health JV; AI-based pandemic management system)
Q3. Any update on past months DM announcement regarding Lotte, Sees/Samsung, RPA 7-11 and Lotte-DM JV fot South Korean Min. of Health?
-
Lotte, July 10th NR DM announced it sold its technology and solution to Lotte Canon, Lotte Supermarket, Lotte Global Logis, and Lotte Home Shopping for approximate sales of $1.0 million.
-
SeeS Solutions Inc sales agreement. DM announced SeeS will utilize its technologies as an automated operating solution for its large corporate customers like Samsung Electronics/ SDI as well as several banks and insurance companies for approximate sales of $2.6 million per annum .
-
Robotic Process Automation (RPA). Sales agreement with 7-Eleven Korea for RPA.
-
Joint Lotte-DM Co-bid to the Ministry of Health in South Korea. In an April announcement it was stated that a Joint Lotte-DM bid was submitted to provide AI solutions to the South Korean Ministry of Health- Welfare, Food, & Drug,
-
AI-based pandemic management system. In October 2020 DM announced it’s developing a pandemic management system building on its Nexalogy AI to create automated systems that track COVID-19 outbreaks.
2. COVID-19 testing
Q4. Although it provides welcome income, has COVID-19 testing distracted DM’s AI business? (i.e. temperature scanners - opportunity cost)
i. Test kit approvals and opportunities (i.e. Michigan, California, travel, mining and film industries).
Q5. Given the EU, US, Canada revamped strategies to increase COVID-19 testing, how has DM been fairing, beyond the mining and film/TV industry tests sales? Are there any updates on the following?
-
In June DM announced it had 3 FDA-approved C-19 tests, Health Canada (“HC”) approval, Kingdom of Saudi Arabia...and CE marking certification (“CE”) for European Economic Area (“EEA”) countries was “...exploring opportunities with Michigan Economic Development Corporation and Governor's Office of Business and Economic Development in California looking into retail, film, healthcare opportunities.”
-
Travel industry. Over the past days, weeks and months DM alluded to testing opportunities with the travel industry, including the likes of Air Canada, airports, cruise line ports and Caribbean countries (i.e. Antigua).
-
Mining. Last announcement was 3 September, in the amount of $1.6M for 50,000 COVID-19 test kits manufactured by 1drop Inc.
-
Film Industry. On 28 October 2020 DM indicated that, based on 4,000 tests/week and on-track to execute on approximately 10,000 tests per week on a progressive basis.”
ii. Temperature scanners. In October 2020 DM indicated it “...as begun deploying its MiCovid Cam Temperature Scanners to COVID-19 testing customers in the market…”. Although an interesting addition to DM’s C-19 efforts, isn’t this an additional distraction to its AI core mandate, given C-19 testing likely already take significant attention? (Opportunity cost)
iii. Screening Solutions for the education sector. On 6 August 2020 DM announced that “...it had begun rolling out its screening solutions for health and safety in the education sector…”
Q6. Any developments on that front?
3. PR strategy (PR, NRs, Comms). Following regular NRs, over the past months, many of which had little to no impact on DM’s share price, contract announcements have not taken place in November.
Q7. Is this a deliberate approach to reducing NRs - in light of low impact - or a reflection of the lack of business being confirmed (i.e. the 21 Oct AGM highlighted that a series of contracts would be announced in the following 7-10 days but this has not materialized)?
4. Other
i. OTCQB listing. 30 July DM announced it has commenced the process to upgrade to OTCQB Market exchange.
Q8. Any update on OTCQB and on DM’s ambitions to list on a U.S. stock exchange such as NASDAQ and NYSE?
ii. Annual/Q4 Results.
Q9. As highlighted by the current share price, Q3 results do not appear to have met expectations. Any outlook to numbers of Annual`Q4 Results (in what manner those will be better than Q3)?
iii. Added value of Directors, BOD members:
Q10. Over the past months several Directors and BOD joined DM (Jim Peterson, Benj Gallander, Todd Shapiro and Paul Haber) with significant fanfare but, to date, contribution to DM for some has proven lackluster.Any tangible way in which shareholders can expect to see them contribute in a more meaningful way in the coming months?